Ceramide-like lipid-based delivery vehicles and uses thereof
AssigneeChildren's Medical Center Corporation
InventorsWayne I. Lencer, Daniel J F Chinnapen, Richard I Duclos
Life of this patent
Estimating the term…
Loading patent…
AssigneeChildren's Medical Center Corporation
InventorsWayne I. Lencer, Daniel J F Chinnapen, Richard I Duclos
Estimating the term…
Provided herein, in some aspects, are delivery vehicles comprising a ceramide and an agent to be delivered attached to the ceramide. In some embodiments, the ceramide does not comprise a fatty acid (i.e., is a sphingosine). In some embodiments, the ceramide comprises a fatty acid. In some embodiments, the ceramide is a glycoceramide. In some embodiments, the agent is attached to the ceramide covalently (e.g., via a linker). In some embodiments, the agent to be delivered is a therapeutic agent. The ceramide is able to deliver the agent to a cell or to a cellular compartment, as well as across the musical barrier. In some embodiments, agents delivered using the ceramide described herein exhibit longer half-life, compared to agents delivered alone. Methods of delivering a therapeutic agent to a subject for treating a disease using the ceramide delivery vehicle are also provided.
A delivery vehicle comprising a ceramide and an agent to be delivered, wherein the ceramide:
-4. (canceled)
-10. (canceled)
-21. (canceled)
-26. (canceled)
-31. (canceled)
(canceled)
-91. (canceled)
-97. (canceled)
-103. (canceled)
Dependencies are inferred from the claim text.